SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-022002
Filing Date
2020-02-14
Accepted
2020-02-14 17:03:55
Documents
13
Period of Report
2020-02-11
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm206687d1_8k.htm   iXBRL 8-K 35627
  Complete submission text file 0001104659-20-022002.txt   286718

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abbv-20200211.xsd EX-101.SCH 4481
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20200211_def.xml EX-101.DEF 30228
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20200211_lab.xml EX-101.LAB 41943
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20200211_pre.xml EX-101.PRE 28431
6 EXTRACTED XBRL INSTANCE DOCUMENT tm206687d1_8k_htm.xml XML 9939
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 20621672
SIC: 2834 Pharmaceutical Preparations